Published in Gut on July 01, 2002
Early satiety in cancer patients: a common and important but underrecognized symptom. Support Care Cancer (2006) 1.45
Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions. Compr Physiol (2014) 0.86
Melatonin Attenuates Noise Stress-induced Gastrointestinal Motility Disorder and Gastric Stress Ulcer: Role of Gastrointestinal Hormones and Oxidative Stress in Rats. J Neurogastroenterol Motil (2015) 0.79
Effect of explosive noise on gastrointestinal transit and plasma levels of polypeptide hormones. World J Gastroenterol (2006) 0.76
The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med (1995) 6.17
Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci (1999) 2.20
Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med (1993) 2.05
Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatr Res (2000) 1.89
Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science (1984) 1.87
Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res (1983) 1.86
Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci U S A (2000) 1.69
In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology (1996) 1.57
Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol (2001) 1.49
Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. Am J Physiol (1999) 1.46
Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc Natl Acad Sci U S A (1995) 1.45
Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci (1996) 1.40
Corticotropin-releasing factor directly mediates colonic responses to stress. Am J Physiol (1987) 1.39
Characterization of ovine hypothalamic hypophysiotropic TSH-releasing factor. Nature (1970) 1.36
Role of CRF in stress-related alterations of gastric and colonic motor function. Ann N Y Acad Sci (1993) 1.33
In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology (1982) 1.32
Psychological stress-induced accelerated colonic transit in rats involves hypothalamic corticotropin-releasing factor. Gastroenterology (1993) 1.29
Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats. Gastroenterology (2000) 1.26
Water-avoidance stress-induced c-fos expression in the rat brain and stimulation of fecal output: role of corticotropin-releasing factor. Brain Res (1994) 1.25
Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proc Soc Exp Biol Med (1997) 1.21
Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion. Annu Rev Physiol (1986) 1.14
Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats. Brain Res (2001) 1.09
Peripheral urocortin delays gastric emptying: role of CRF receptor 2. Am J Physiol (1999) 0.99
Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. J Immunol (1988) 0.99
Thyrotropin-releasing hormone: stimulation of colonic activity following intracerebroventricular administration. Science (1977) 0.96
Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors. Am J Physiol (1998) 0.95
Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. Curr Pharm Des (1999) 0.95
Central nervous system action of peptides to influence gastrointestinal motor function. Gastroenterology (1990) 0.91
Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats. J Pharmacol Exp Ther (1999) 0.89
Central regulation of gastric emptying of solid nutrient meals by corticotropin releasing factor. Neurogastroenterol Motil (1997) 0.88
Centrally administered thyrotropin-releasing hormone (TRH) stimulates colonic transit and diarrhea production by a vagally mediated serotonergic mechanism in the rabbit. J Pharmacol Exp Ther (1982) 0.85
On the neuropharmacology of thyrotropin releasing hormone (TRH). Prog Neurobiol (1979) 0.85
Characterization and autoradiographic localization of TRH receptors in sections of rat brain. Brain Res (1984) 0.84
Thyrotropin-releasing hormone (TRH) receptors. Localization by light microscopic autoradiography in rat brain using [3H][3-Me-His2]TRH as the radioligand. J Neurosci (1985) 0.84
Evidence for alpha 1-adrenergic stimulatory control of in vitro release of immunoreactive thyrotropin-releasing hormone from rat median eminence: in vivo corroboration. Endocrinology (1985) 0.84
Thyrotropin-releasing hormone (TRH) acts centrally to stimulate gastric contractility in rats. Life Sci (1987) 0.83
Central regulation of intestinal motility by somatostatin and cholecystokinin octapeptide. Science (1982) 0.83
Direct evidence of short-term cold-induced TRH release in the median eminence of unanesthetized rats. Neuroendocrinology (1983) 0.83
Autoradiographic localization of thyrotropin-releasing hormone receptors in the rat central nervous system. J Neurosci (1985) 0.83
CRF in the paraventricular nucleus of the hypothalamus stimulates colonic motor activity in fasted rats. Peptides (1993) 0.82
Physiological evidence for alpha 1-adrenergic facilitatory control of the cold-induced TRH release in the rat, obtained by push-pull cannulation of the median eminence. Neurosci Lett (1989) 0.81
Effects of corticotropin-releasing factor, corticotropin and cortisol on gastrointestinal motility in dogs. Peptides (1986) 0.81
Gastric effects of thyrotropin-releasing hormone microinjected into the dorsal vagal nucleus in cats. Life Sci (1991) 0.81
Mechanisms underlying the anti-inflammatory actions of central corticotropin-releasing factor. Am J Physiol (1999) 0.79
Regulation of canine gallbladder motility by brain peptides. Gastroenterology (1993) 0.78
Autoradiographic localization of thyrotropin-releasing hormone (TRH) receptors in human spinal cord. Neurology (1985) 0.78
Blockade by naloxone and naltrexone of the TRH-induced stimulation of colonic transit in the rabbit. Eur J Pharmacol (1985) 0.77
Studies of thyrotropin-releasing hormone (TRH)-induced defecation in cats. Pharmacol Biochem Behav (1987) 0.77
Thyrotropin releasing hormone (TRH): possible physiological functions not related to the neuroendocrine system. Rev Pure Appl Pharmacol Sci (1984) 0.76
Thyrotropin releasing hormone: centrally mediated effects on gastrointestinal motor activity. J Pharmacol Exp Ther (1982) 0.76
Central sites of action of gastrointestinal drugs. Gastroenterology (1978) 0.76
Microbial degradation of oil spills enhanced by a slow-release fertilizer. Appl Environ Microbiol (1976) 1.41
The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut (2000) 1.23
Ecological components and evolution of selfing in the freshwater snail Galba truncatula. J Evol Biol (2005) 1.09
Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans. Am J Physiol Regul Integr Comp Physiol (2001) 1.00
Two-marker protein profile predicts poor prognosis in patients with early rectal cancer. Br J Cancer (2008) 0.96
Evolutionary implications of a high selfing rate in the freshwater snail Lymnaea truncatula. Evolution (2003) 0.95
Clinical outcome and quality of life after gastric and distal esophagus replacement with an ileocolon interposition. J Gastrointest Surg (2000) 0.94
Effect of yacon (Smallanthus sonchifolius) on colonic transit time in healthy volunteers. Digestion (2008) 0.87
Colonic involvement in non-necrotizing acute pancreatitis: correlation of CT findings with the clinical course of affected patients. Eur Radiol (2002) 0.84
Microsatellites in the hermaphroditic snail, Lymnaea truncatula, intermediate host of the liver fluke, Fasciola hepatica. Mol Ecol (2000) 0.81
Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis. Gut (2005) 0.81
Ileocecal reservoir reconstruction after total mesorectal excision: functional results of the long-term follow-up. Int J Colorectal Dis (2004) 0.79
Antiviral compounds. 8. Aminoacethydrazones of aromatic alpha-ketoaldehydes. J Med Chem (1966) 0.78
Subjective and functional results after replacement of the stomach with an ileocecal segment: a prospective study of 20 patients. Int J Colorectal Dis (2002) 0.78
8-hydroxyinoline derivatives. Synthesis and biological evaluation of arylglyoxal N-7-amino-5-substituted 8-hydroxyquinoline hemiacetals and 5-phenylglyoxylidenamin-8-hydroxyquinolines. J Med Chem (1970) 0.77
Biologics in inflammatory disease: infliximab associated risk of lymphoma development. Gut (2005) 0.76
Antibacterial nitrofuran derivatives. 4. 5-Nitro-2-furaldehyde hydrazoniumacethydrazones. J Med Chem (1971) 0.75
[Evaluation of antiviral drugs by means of infection with the influenza virus in the mouse]. Boll Chim Farm (1966) 0.75
[Lymphogranuloma venereum. An old disease in a new dress]. Internist (Berl) (2011) 0.75
Antiviral compounds. XV. P-substituted phenylglyoxal-N-acylamido-hemiacetals. Arzneimittelforschung (1973) 0.75
[7-Nitro-8-cinnamoyloxy- and 7-nitro-8,alpha-methylcinnamoyloxyquinolines with antimicrobial and antifungal activity]. Boll Chim Farm (1973) 0.75
[Irritable colon]. Ther Umsch (1997) 0.75
[Testing virus-active substances on the model of influenza virus infection of mice]. Arzneimittelforschung (1967) 0.75
Antiviral compounds. XIV. Arzneimittelforschung (1973) 0.75
[The infection of mice with the mouse hepatitis virus (MHV 3). I. Analysis of several experimental data from the view point of the single hit theory]. Arch Gesamte Virusforsch (1969) 0.75
Antibacterial nitrofuran derivatives. I. 5-nitro-2-furaldehyde semicarbazones and thiosemicarbazones. J Med Chem (1967) 0.75
Antimicrobial activity os some 7-nitro-and 7-amino-dialkylaminomethyl-8-hydroxyquinolines. Arzneimittelforschung (1973) 0.75
Antimicrobial activity of 5-nitro-2-furaldehyde-N'-methyl-N-piperazino-acethydrazone, a new hydrosoluble nitrofuran derivative. Studies on in vivo chemotherapeutic activity. Chemotherapy (1973) 0.75
Thiabenzazonium, a new 1,5-benzodiazepine derivative with antimicrobial activity. Experientia (1975) 0.75
Antiviral compounds. XVI. p-Alkylthiophenylglyoxals and their derivatives. Farmaco Sci (1974) 0.75
[Studies on the effects of some aromatic glycoxals on biological macromolecules. II]. Zentralbl Bakteriol Orig (1966) 0.75
Search for a synergism with different drugs in the field of antiviral chemotherapy. Chemotherapy (1971) 0.75
Antibacterial nitrofuran derivatives. 2. 5-Nitro-2-furaldehyde aminoacethydrazones. J Med Chem (1971) 0.75
[7-Nitro-8-benzoyloxyquinolines with antimicrobial and antifungal activity]. Boll Chim Farm (1973) 0.75
[Portal vein thrombosis in a young patient with severe abdominal pain: a case report]. Praxis (Bern 1994) (2007) 0.75
Arylglyoxal N,N-disubstituted hydrazones with antiviral and antifungal activity. J Med Chem (1970) 0.75
[Rectum replacement by colon reservoir: good quality of life thanks to minimal morbidity?]. Langenbecks Arch Chir Suppl Kongressbd (1997) 0.75
[What is your diagnosis? Superior mesenteric artery (compression) syndrome]. Praxis (Bern 1994) (2003) 0.75
Antimicrobial activity of a series of new 5-nitro-2-furaldehyde aminoacethydrazones. Chemotherapy (1972) 0.75
Antimicrobial activity of 5-nitro-2-furaldehyde-N'-methyl-N-piperazinoacethydrazone, a new hydrosoluble nitrofurane derivative. I. In vivo antibacterial activity. Chemotherapy (1972) 0.75
[Ileo-cecal segment as stomach substitute]. Langenbecks Arch Chir Suppl Kongressbd (1998) 0.75
Nifurpipone, a new nitrofuran with a large antimicrobial spectrum. Experientia (1971) 0.75
[Experimental pyelonephritis and cystitis as models in evaluating chemotherapeutic drugs]. Boll Chim Farm (1967) 0.75
Patents and literature. Appl Biochem Biotechnol (1982) 0.75
Antibacterial nitrofuran derivatives. V. 5-Nitro-2-furaldehyde substituted aniles. Arzneimittelforschung (1972) 0.75
[Abdominal pain of unknown origin with changed stool habits. Irritable bowel syndrome]. Praxis (Bern 1994) (2002) 0.75
[Studies on the effect of various aromatic glyoxals on biological macromolecules. I. Mechanism of the inactivation of bacteriophages]. Zentralbl Bakteriol Orig (1964) 0.75
7-nitro-8-acyloxyquinolines with antimicrobial and antifungal activity. Arzneimittelforschung (1974) 0.75
Antibacterial nitrofuran derivatives. 3. 5-Nitro-2-furaldehyde piperazinoacylhydrazones. J Med Chem (1971) 0.75
Patents and literature. Appl Biochem Biotechnol (1982) 0.75